{'52WeekChange': 1.5562501,
 'SandP52WeekChange': None,
 'address1': '6310 Nancy Ridge Drive',
 'address2': 'Suite 101',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 3.86,
 'askSize': 1000,
 'averageDailyVolume10Day': 213800,
 'averageVolume': 294439,
 'averageVolume10days': 213800,
 'beta': 1.914845,
 'beta3Year': None,
 'bid': 3.86,
 'bidSize': 1000,
 'bookValue': 1.325,
 'category': None,
 'circulatingSupply': None,
 'city': 'San Diego',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.14,
 'dayLow': 3.81,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -2.631,
 'enterpriseToRevenue': 4.44,
 'enterpriseValue': 104090144,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 3.7884285,
 'fiftyTwoWeekHigh': 4.45,
 'fiftyTwoWeekLow': 1.223,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 31277444,
 'forwardEps': -1.67,
 'forwardPE': -2.3053892,
 'fromCurrency': None,
 'fullTimeEmployees': 68,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.18341999,
 'heldPercentInstitutions': 0.47224,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/cidara.com',
 'longBusinessSummary': 'Cidara Therapeutics, Inc., a biotechnology company, '
                        'focuses on the discovery, development, and '
                        'commercialization of novel anti-infectives for the '
                        'treatment of diseases in the United States. Its lead '
                        'product candidate is rezafungin acetate, a novel '
                        'molecule in the echinocandin class of antifungals for '
                        'the treatment and prevention of serious invasive '
                        'fungal infections, including candidemia and invasive '
                        'candidiasis, which are fungal infections associated '
                        'with high mortality rates. The company, through its '
                        'Cloudbreak platform, focuses on the treatment of '
                        'infectious diseases that include viral and bacterial '
                        'infections. The company was formerly known as K2 '
                        'Therapeutics, Inc. and changed its name to Cidara '
                        'Therapeutics, Inc. in June 2014. Cidara Therapeutics, '
                        'Inc. was founded in 2012 and is headquartered in San '
                        'Diego, California.',
 'longName': 'Cidara Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 158297360,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_266264552',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -41832000,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.1,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '858-752-6170',
 'previousClose': 4.09,
 'priceHint': 4,
 'priceToBook': 2.9056602,
 'priceToSalesTrailing12Months': 6.75186,
 'profitMargins': -1.7842599,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.14,
 'regularMarketDayLow': 3.81,
 'regularMarketOpen': 4.1,
 'regularMarketPreviousClose': 4.09,
 'regularMarketPrice': 4.1,
 'regularMarketVolume': 189308,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 41116200,
 'sharesPercentSharesOut': 0.0537,
 'sharesShort': 2207351,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1571766,
 'shortName': 'Cidara Therapeutics, Inc.',
 'shortPercentOfFloat': 0.0622,
 'shortRatio': 5.46,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'CDTX',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.331,
 'twoHundredDayAverage': 3.1931655,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'd09eb400-8190-3726-9b22-86bfb18853b0',
 'volume': 189308,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.cidara.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92121'}